Adipose-Derived Biogenic Nanoparticles for Suppression of Inflammation.
暂无分享,去创建一个
F. Rückert | B. Ji | Y. Talmon | A. Quiñones‐Hinojosa | J. Wolfram | R. Al-kharboosh | S. Busatto | A. Pham | A. Suh | S. Shapiro | Laura J. Lewis-Tuffin | Irina Davidovich | Qikun Wang | Sierra A Walker | Ming Tian | Taylor Ticer | Annie Suh | Sierra A. Walker | Joy Wolfram | R. Al‐kharboosh | R. Al-Kharboosh
[1] Q. Yuan,et al. Extracellular vesicles from human adipose derived stem cells for the improvement of angiogenesis and fat grafting application. , 2020, Plastic and reconstructive surgery.
[2] J. Wolfram,et al. Extracellular vesicle-based drug delivery systems for cancer treatment , 2019, Theranostics.
[3] J. Wolfram,et al. Adipose-derived cellular and cell-derived regenerative therapies in dermatology and aesthetic rejuvenation , 2019, Ageing Research Reviews.
[4] K. Rezvani,et al. Mesenchymal stem cell-derived exosomes for clinical use , 2019, Bone Marrow Transplantation.
[5] Chao Han,et al. Pretreatment with Salvia miltiorrhiza Polysaccharides Protects from Lipopolysaccharides/d-Galactosamine-Induced Liver Injury in Mice through Inhibiting TLR4/MyD88 Signaling Pathway. , 2019, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[6] G. Evans,et al. Adipose-derived stem cell extracellular vesicles: A systematic review✰. , 2019, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.
[7] H. Chou,et al. Maternal inflammation exacerbates neonatal hyperoxia-induced kidney injury in rat offspring , 2019, Pediatric Research.
[8] Hong Tang,et al. Apolipoprotein A5 alleviates LPS/d-GalN-induced fulminant liver failure in mice by inhibiting TLR4-mediated NF-κB pathway , 2019, Journal of Translational Medicine.
[9] J. Wolfram,et al. Organotropic drug delivery: Synthetic nanoparticles and extracellular vesicles , 2019, Biomedical Microdevices.
[10] James E. Tomkins,et al. Secretome of adipose-derived mesenchymal stem cells promotes skeletal muscle regeneration through synergistic action of extracellular vesicle cargo and soluble proteins , 2019, Stem Cell Research & Therapy.
[11] Mauro Ferrari,et al. Clinical Cancer Nanomedicine. , 2019, Nano today.
[12] Yueqiao Xu,et al. Exosomes from adipose-derived mesenchymal stem cells prevent cardiomyocyte apoptosis induced by oxidative stress , 2019, Cell Death Discovery.
[13] Y. Takakura,et al. Preservation of exosomes at room temperature using lyophilization , 2018, International journal of pharmaceutics.
[14] D. Dickson,et al. Tangential Flow Filtration for Highly Efficient Concentration of Extracellular Vesicles from Large Volumes of Fluid , 2018, Cells.
[15] Jing Xu,et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines , 2018, Journal of Extracellular Vesicles.
[16] J. Merola,et al. TNF Inhibitor-Induced Psoriasis: Proposed Algorithm for Treatment and Management , 2018, Journal of psoriasis and psoriatic arthritis.
[17] M. Ferrari,et al. Chloroquine and nanoparticle drug delivery: A promising combination , 2018, Pharmacology & therapeutics.
[18] B. Péault,et al. Higher Pericyte Content and Secretory Activity of Microfragmented Human Adipose Tissue Compared to Enzymatically Derived Stromal Vascular Fraction , 2018, Stem cells translational medicine.
[19] C. Scarlett,et al. Lipidomic profiling of extracellular vesicles derived from prostate and prostate cancer cell lines , 2018, Lipids in Health and Disease.
[20] J. Dai,et al. Pro inflammatory stimuli enhance the immunosuppressive functions of adipose mesenchymal stem cells-derived exosomes , 2018, Scientific Reports.
[21] S. Kristensen,et al. Investigation of procoagulant activity in extracellular vesicles isolated by differential ultracentrifugation , 2018, Journal of extracellular vesicles.
[22] J. Wolfram,et al. Extracellular vesicle therapeutics for liver disease , 2018, Journal of controlled release : official journal of the Controlled Release Society.
[23] J. Lötvall,et al. Detailed analysis of the plasma extracellular vesicle proteome after separation from lipoproteins , 2018, Cellular and Molecular Life Sciences.
[24] William C Lamanna,et al. Maintaining consistent quality and clinical performance of biopharmaceuticals , 2018, Expert opinion on biological therapy.
[25] Dongfeng Guo,et al. Exosomes from MiR-126-Overexpressing Adscs Are Therapeutic in Relieving Acute Myocardial Ischaemic Injury , 2017, Cellular Physiology and Biochemistry.
[26] Lining Zhang,et al. Exosomes From Adipose-Derived Stem Cells Attenuate Adipose Inflammation and Obesity Through Polarizing M2 Macrophages and Beiging in White Adipose Tissue , 2017, Diabetes.
[27] M. Ferrari,et al. A chloroquine-induced macrophage-preconditioning strategy for improved nanodelivery , 2017, Scientific Reports.
[28] Mauro Ferrari,et al. Contribution of Kupffer cells to liposome accumulation in the liver. , 2017, Colloids and surfaces. B, Biointerfaces.
[29] Qing Xu,et al. Human macrophages survive and adopt activated genotypes in living zebrafish , 2017, Scientific Reports.
[30] M. Ferrari,et al. Strategies for improving drug delivery: nanocarriers and microenvironmental priming , 2017, Expert opinion on drug delivery.
[31] Y. Talmon,et al. A direct-imaging cryo-EM study of shedding extracellular vesicles from leukemic monocytes. , 2017, Journal of structural biology.
[32] Romaric Lacroix,et al. Methodological Guidelines to Study Extracellular Vesicles. , 2017, Circulation research.
[33] Mauro Ferrari,et al. Taking the vehicle out of drug delivery. , 2017, Materials today.
[34] E. Galanis,et al. Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects. , 2017, Current cancer drug targets.
[35] M. Barbosa,et al. Extracellular Vesicles: Immunomodulatory messengers in the context of tissue repair/regeneration , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[36] Hongguang Zhang,et al. hucMSC Exosome-Derived GPX1 Is Required for the Recovery of Hepatic Oxidant Injury. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.
[37] R. Cancedda,et al. Mesenchymal Stem Cell‐Derived Extracellular Vesicles as Mediators of Anti‐Inflammatory Effects: Endorsement of Macrophage Polarization , 2017, Stem cells translational medicine.
[38] M. Ferrari,et al. Enzyme-responsive multistage vector for drug delivery to tumor tissue. , 2016, Pharmacological research.
[39] Parvin Akbarzadehlaleh,et al. Mesenchymal Stem Cell-Derived Exosomes: New Opportunity in Cell-Free Therapy. , 2016, Advanced pharmaceutical bulletin.
[40] M. Ferrari,et al. Hesperetin Liposomes for Cancer Therapy. , 2016, Current drug delivery.
[41] C. Ventura,et al. Adipose Tissue and Mesenchymal Stem Cells: State of the Art and Lipogems® Technology Development , 2016, Current Stem Cell Reports.
[42] A. Sudo,et al. Guanabenz Downregulates Inflammatory Responses via eIF2α Dependent and Independent Signaling , 2016, International journal of molecular sciences.
[43] K. Sakthivel,et al. Acacia ferruginea inhibits inflammation by regulating inflammatory iNOS and COX-2 , 2016, Journal of immunotoxicology.
[44] A. Hill,et al. Techniques used for the isolation and characterization of extracellular vesicles: results of a worldwide survey , 2016, Journal of extracellular vesicles.
[45] Heikki Saari,et al. Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[46] Z. Giricz,et al. Isolation of Exosomes from Blood Plasma: Qualitative and Quantitative Comparison of Ultracentrifugation and Size Exclusion Chromatography Methods , 2015, PloS one.
[47] Mauro Ferrari,et al. Safety of Nanoparticles in Medicine. , 2015, Current drug targets.
[48] V. Govorun,et al. Isolation of exosomes by differential centrifugation: Theoretical analysis of a commonly used protocol , 2015, Scientific Reports.
[49] S. Lim,et al. Mesenchymal stem cell exosomes. , 2015, Seminars in cell & developmental biology.
[50] Go-woon Kim,et al. IL-6 inhibitors for treatment of rheumatoid arthritis: past, present, and future , 2015, Archives of pharmacal research.
[51] Shaowu Cheng,et al. HDL and cognition in neurodegenerative disorders , 2014, Neurobiology of Disease.
[52] Verónica Álvarez,et al. Immunomodulatory Potential of Human Adipose Mesenchymal Stem Cells Derived Exosomes on in vitro Stimulated T Cells , 2014, Front. Immunol..
[53] Toshio Tanaka,et al. IL-6 in inflammation, immunity, and disease. , 2014, Cold Spring Harbor perspectives in biology.
[54] J. Schageman,et al. Analysis of the RNA content of the exosomes derived from blood serum and urine and its potential as biomarkers , 2014, Philosophical Transactions of the Royal Society B: Biological Sciences.
[55] Hemlata,et al. Adverse events related to blood transfusion , 2014, Indian journal of anaesthesia.
[56] M. Ferrari,et al. Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells , 2014, Journal of microencapsulation.
[57] E. Yoon,et al. Immunosuppressive activity of adipose tissue-derived mesenchymal stem cells in a rat model of hind limb allotransplantation. , 2014, Transplantation proceedings.
[58] B. Yu,et al. Exosomes Derived from Mesenchymal Stem Cells , 2014, International journal of molecular sciences.
[59] R. Nieuwland,et al. Single-step isolation of extracellular vesicles by size-exclusion chromatography , 2014, Journal of extracellular vesicles.
[60] R. Pink,et al. Routes and mechanisms of extracellular vesicle uptake , 2014, Journal of extracellular vesicles.
[61] K. Braeckmans,et al. Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[62] Giuseppe Battaglia,et al. Exploiting endocytosis for nanomedicines. , 2013, Cold Spring Harbor perspectives in biology.
[63] Winston Patrick Kuo,et al. Current methods for the isolation of extracellular vesicles , 2013, Biological chemistry.
[64] G. Teng,et al. Let-7b Is Involved in the Inflammation and Immune Responses Associated with Helicobacter pylori Infection by Targeting Toll-Like Receptor 4 , 2013, PloS one.
[65] G. Camussi,et al. Role of stem-cell-derived microvesicles in the paracrine action of stem cells. , 2013, Biochemical Society transactions.
[66] Lynne T. Bemis,et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research , 2013, Journal of extracellular vesicles.
[67] K. Wilhelmsen,et al. Alveolar Macrophages and Toll-like Receptor 4 Mediate Ventilated Lung Ischemia Reperfusion Injury in Mice , 2012, Anesthesiology.
[68] Y. Barenholz. Doxil®--the first FDA-approved nano-drug: lessons learned. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[69] M. Masserini,et al. Cellular uptake of coumarin-6 as a model drug loaded in solid lipid nanoparticles. , 2011, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[70] K. Vickers,et al. MicroRNAs are Transported in Plasma and Delivered to Recipient Cells by High-Density Lipoproteins , 2011, Nature Cell Biology.
[71] D. Stumpo,et al. Inflammation: cytokines and RNA‐based regulation , 2010, Wiley interdisciplinary reviews. RNA.
[72] M. Casiraghi,et al. Novel critical role of Toll-like receptor 4 in lung ischemia-reperfusion injury and edema. , 2009, American journal of physiology. Lung cellular and molecular physiology.
[73] A. Shimamoto,et al. Toll-like receptor 4 mediates lung ischemia-reperfusion injury. , 2006, The Annals of thoracic surgery.
[74] J Bruce German,et al. Lipoproteins: When size really matters. , 2006, Current opinion in colloid & interface science.
[75] M. Hochberg. COX-2 selective inhibitors in the treatment of arthritis: a rheumatologist perspective. , 2005, Current topics in medicinal chemistry.
[76] A. Gotto,et al. Functional Interplay Between the Macrophage Scavenger Receptor Class B Type I and Pitavastatin (NK-104) , 2004, Circulation.
[77] A. Tall,et al. High Density Lipoprotein (HDL) Particle Uptake Mediated by Scavenger Receptor Class B Type 1 Results in Selective Sorting of HDL Cholesterol from Protein and Polarized Cholesterol Secretion* , 2001, The Journal of Biological Chemistry.
[78] F. Kronenberg,et al. Effect of sample storage on the measurement of lipoprotein[a], apolipoproteins B and A-IV, total and high density lipoprotein cholesterol and triglycerides. , 1994, Journal of lipid research.
[79] R P Carlson,et al. The antiinflammatory action of guanabenz is mediated through 5-lipoxygenase and cyclooxygenase inhibition. , 1987, European journal of pharmacology.
[80] R. N. Brogden,et al. Guanabenz , 1983, Drugs.
[81] S. Jay,et al. Preservation and Storage Stability of Extracellular Vesicles for Therapeutic Applications , 2017, The AAPS Journal.
[82] B. De Geest,et al. Therapeutic potential of HDL in cardioprotection and tissue repair. , 2015, Handbook of experimental pharmacology.
[83] M. Carafa,et al. Liposomal chemotherapeutics. , 2013, Future oncology.
[84] J. Joh,et al. Enhancement of the immunosuppressive effect of human adipose tissue-derived mesenchymal stromal cells through HLA-G1 expression. , 2012, Cytotherapy.
[85] M. Federspiel,et al. Manufacture of measles viruses. , 2011, Methods in molecular biology.
[86] Jun-Ming Zhang,et al. Cytokines, Inflammation, and Pain , 2007, International anesthesiology clinics.
[87] D. Prockop,et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.